The Reshaping of Modifiable Risk Factors as a Strategy to Prevent the Development of Rheumatoid Arthritis

Affiliations

• ¹ F. Caso, MD, PhD, R. Scarpa, MD, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples.
• ² R. Giacomelli, MD, PhD, Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, and Rheumatology and Clinical Immunology, Department of Medicine, University of Rome "Campus Biomedico," School of Medicine, Rome.
• ³ M. Nunziato, PhD, F. Di Maggio, PhD, F. Salvatore, MD, PhD, Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, and "CEINGE - Biotecnologie Avanzate Franco Salvatore," Naples.
• ⁴ F. Caso, MD, PhD, R. Scarpa, MD, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples; profrscarpa@gmail.com salvator@unina.it.
• ⁵ P. Ruscitti, MD, PhD, Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. P. Ruscitti and F. Salvatore contributed equally to this article as co-senior authors.
• ⁶ M. Nunziato, PhD, F. Di Maggio, PhD, F. Salvatore, MD, PhD, Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, and "CEINGE - Biotecnologie Avanzate Franco Salvatore," Naples; profrscarpa@gmail.com salvator@unina.it.